AD-associated mutations in the genes APP, PSEN1, and PSEN2 promote Aβ formation by favoring proteolytic processing of APP via the β- or γ-secretase pathway rather than via the non-amyloidogenic α-secretase pathway. This evidence concerns the gene PSEN1 and Alzheimer disease.